PNC Financial Services Group’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $358 | Hold |
|
|||||
|
2025
Q1 | $381 | Buy |
|
|||||
|
2024
Q4 | $179 | Hold |
|
|||||
|
2024
Q3 | $233 | Hold |
|
|||||
|
2024
Q2 | $410 | Hold |
|
|||||
|
2024
Q1 | $324 | Sell |
|
|||||
|
2023
Q4 | $2.75K | Sell |
|
|||||
|
2023
Q3 | $1.76K | Hold |
|
|||||
|
2023
Q2 | $1.98K | Hold |
|
|||||
|
2023
Q1 | $2.58K | Hold |
|
|||||
|
2022
Q4 | $4.27K | Sell |
|
|||||
|
2022
Q3 | $8K | Hold |
|
|||||
|
2022
Q2 | $5K | Sell |
|
|||||
|
2022
Q1 | $15K | Buy |
|
|||||
|
2021
Q4 | $16K | Hold |
|
|||||
|
2021
Q3 | $18K | Sell |
|
|||||
|
2021
Q2 | $78K | Buy |
|
|||||
|
2021
Q1 | $62K | Buy |
|
|||||
|
2020
Q4 | $79K | Sell |
|
|||||
|
2020
Q3 | $65K | Buy |
|
|||||
|
2020
Q2 | $61K | Buy |
|
|||||
|
2020
Q1 | $32K | Buy |
|
|||||
|
2019
Q4 | $14K | Sell |
|
|||||
|
2019
Q3 | $15K | Buy |
|
|||||
|
2019
Q2 | $12K | Sell |
|
|||||
|
2019
Q1 | $1.8M | Buy |
|
|||||
|
2018
Q4 | $1.22M | Sell |
|
|||||
|
2018
Q3 | $1.56M | Buy |
|
|||||
|
2018
Q2 | $1.9M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $24K | Hold |
|
|||||
|
2017
Q2 | $21K | Hold |
|
|||||
|
2017
Q1 | $23K | Hold |
|
|||||
|
2016
Q4 | $20K | Buy |
|
|||||
|
2016
Q3 | $13K | Hold |
|
|||||
|
2016
Q2 | $14K | Sell |
|
|||||
|
2016
Q1 | $53K | Sell |
|
|||||
|
2015
Q4 | $106K | Buy |
|
|||||
|
2015
Q3 | $51K | Buy |
|
|||||
|
2015
Q2 | $62K | Buy |
|